Two European companies have been forced to slash the price targets for their initial public offerings, blaming reverberations from last week's market fallout.

In the wake of alternative investment firms Brevan Howard and 3i having to almost halve their initial public offerings, Italian pharmaceutical firm Cosmo, and German engineering group Kormi have slashed their floats, citing "turbulent markets".